Abstract
EDITOR—Because of a series of questions I have received about the current clinical use of human albumin in critically ill patients, I wish to clarify the message that I intended my editorial last week to convey.1 Given the current evidence as summarised by the Cochrane albumin reviewers group,).2 the …